- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- January 2025
- 124 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- May 2024
- 133 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- February 2024
- 180 Pages
Global
From €4522EUR$4,969USD£3,877GBP
Preeclampsia is a serious medical condition that can occur during pregnancy and is characterized by high blood pressure and protein in the urine. It can lead to serious complications for both the mother and the baby. Treatment for preeclampsia typically involves medications to lower blood pressure and reduce the risk of complications. Sexual and reproductive health drugs are used to treat a variety of conditions related to sexual and reproductive health, including preeclampsia.
These drugs are used to reduce the risk of complications associated with preeclampsia, such as seizures, stroke, and organ damage. They can also help to reduce the risk of preterm birth and improve the health of the mother and baby. Common medications used to treat preeclampsia include angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and calcium channel blockers.
Some of the companies in the preeclampsia drug market include Pfizer, Merck, GlaxoSmithKline, Novartis, and Sanofi. Show Less Read more